Experts discuss association between inflammasomes and acne that may lead to treatments stopping acne before clinical signs emerge.
While many are in early phase studies, most of the new topical options are targeting sebum reduction, a novel pathway to controlling acne, and the data are exciting, one expert says.
New findings support dietary and supplementation practices that can influence acne. One expert discusses modifications in context of protocols for managing the condition.
The AAD’s new guidelines for the care and management of acne vulgaris include several updates for dermatologists, including an increased emphasis on oral antibiotic stewardship and recommendations for use.
Allergan announced in late February that the FDA approved its topical Aczone (dapsone) Gel, 7.5% for treatment of acne vulgaris.
Research shows dermatologists are overprescribing antibiotics for acne treatment, and patients and their parents seem unaware of the consequences, as well as alternatives to antibiotic treatment for acne.
Study demonstrates current antibiotic use for acne therapy far surpasses guideline recommendations and calls for dermatologists to decrease extended courses of antibiotics through early recognition of failure and guiding patients to alternative therapies.
Evidence from recently published papers provides insight to address some common questions pertaining to the safe use of certain acne medications. Learn more
There is an absence of strong evidence supporting the recommendation that cumulative dosing of isotretinoin follow a reference range of 120 to 150 mg/kg. This points to the need for clinicians to treat their patients to achieve clearance of acne rather than adhere to this range.
Clinicians recognize that acne is increasingly presenting in pre-adolescents and that early presentation is also a predictor of worse disease in the future and the potential for scarring. Prompt, aggressive treatment will lead to better outcomes and will reduce the potential for adverse psychosocial effects.